A Case of Recurrent Salivary Duct Carcinoma Negative to HER-2/neu and Androgen Receptor Successfully Treated with Chemoradiation with Docetaxel

[1]  R. Tishler,et al.  Trastuzumab for the treatment of salivary duct carcinoma. , 2013, The oncologist.

[2]  Julie M. Batten,et al.  Detection of Novel Actionable Genetic Changes in Salivary Duct Carcinoma Helps Direct Patient Treatment , 2012, Clinical Cancer Research.

[3]  T. Ettl,et al.  EGFR, HER2, survivin, and loss of pSTAT3 characterize high-grade malignancy in salivary gland cancer with impact on prognosis. , 2012, Human pathology.

[4]  S. Nam,et al.  Treatment results of post-operative radiotherapy in patients with salivary duct carcinoma of the major salivary glands. , 2012, The British journal of radiology.

[5]  R. Tishler,et al.  Salivary gland tumors treated with adjuvant intensity-modulated radiotherapy with or without concurrent chemotherapy. , 2012, International journal of radiation oncology, biology, physics.

[6]  T. Negri,et al.  Treatment relevant target immunophenotyping of 139 salivary gland carcinomas (SGCs). , 2009, Oral oncology.

[7]  J. Sercarz,et al.  Salivary duct carcinoma: A clinical and histologic review with implications for trastuzumab therapy , 2007, Head & neck.

[8]  J. Gilbert,et al.  Phase II trial of taxol in salivary gland malignancies (E1394): A trial of the Eastern Cooperative Oncology Group , 2006, Head & neck.

[9]  T. Löning,et al.  Clinical and immunohistologic typing of salivary duct carcinoma , 2005, Cancer.

[10]  K. Yamazaki,et al.  Sarcomatoid variant of salivary duct carcinoma: clinicopathologic and immunohistochemical study of eight cases with review of the literature. , 2004, American journal of clinical pathology.

[11]  C. Langer,et al.  HER2 Expression in Salivary Gland Carcinomas , 2004, Clinical Cancer Research.

[12]  Joseph I. Clark,et al.  Response to paclitaxel and carboplatin in metastatic salivary gland cancer: A case report , 2002, Head & neck.

[13]  Jun Yao,et al.  Overexpression of ErbB2 blocks Taxol-induced apoptosis by upregulation of p21Cip1, which inhibits p34Cdc2 kinase. , 1998, Molecular cell.